Clinical trial registry record

CDK4/6 Inhibitors in Breast Cancer Elderly Patients: an Observational Ambispective Longitudinal Multicenter Study

A registered study indexed because it matched monitored longevity research terms. Registry status: Recruiting. Registration does not establish safety or effectiveness.

Plain-language guide

Five questions to ask about this record

What this is
A clinical study registration, not a result or recommendation.
Why it may matter
The registry currently reports Recruiting.
Evidence
Registered phase not reported study.
Main limitation
Registration does not prove that the intervention works, is safe, or is available to you.
What changed
Registry metadata was last updated February 10, 2026.
Where to verify
Open the primary registry below for eligibility, locations, contacts, and current status.
Registry ID
NCT07399808
Last registry update
February 10, 2026
Status
Recruiting
Phase
Phase not reported
Sponsor
Fondazione IRCCS Policlinico San Matteo di Pavia
Enrollment
100
Countries
Italy
Match confidence
100%
Source feed
ClinicalTrials.gov
Automated source synopsis

A registered study indexed because it matched monitored longevity research terms. Registry status: Recruiting. Registration does not establish safety or effectiveness.

Evidence snapshot

What the source actually supports

Evidence stage
Phase not reported
Study design
OBSERVATIONAL
Evidence population
Human clinical study registration
Participants
100
Population
ALL · 18 Years
Duration
2025-03-21 to 2026-12-01
Intervention
Comparator
Not reported
Outcomes measured
Evaluate the toxicity rate (both hematological and non-hematological) of any severity level in elderly patients (≥70 ye…; Compare the toxicity rate between elderly and young MBC subjects; — From date of randomization until the date of first…; Compare the rate of switch therapies between elderly and younger EBC subjects; — From date of randomization until the d…; Compare the rate of dose reductions between elderly and younger EBC subjects; — From date of randomization until the da…; Compare the invasive disease free survival (iDFS) between elderly and younger EBC subjects. — from the date of CDK 4/6i…
Reported result
No reusable finding-level result is available in this record.

Main limitationThis is a study registration. No reusable structured result is available here, so it cannot show whether the intervention worked or was safe.

Safety and approvalEligibility, adverse-event details, and clinical decisions must be checked in the official registry and with qualified clinicians. Trial registration is not regulatory approval and does not establish that an intervention is available.

Source supportStructured registry protocol metadata; no finding-level conclusion is generated.

Trial stage · Phase not reportedA trial phase describes development stage; it does not establish a positive result.
Phase 1Phase 2Phase 3Phase 4

Registration and recruitment status do not establish safety, efficacy, or regulatory approval.

Why this record appears here · 100% topic match

The title, summary, or source keywords matched one or more topics followed by immortal.life. A higher percentage means a stronger topic match; it does not rate safety, effectiveness, or study quality.

  • Cancer and ageing · 100%Title contains controlled topic terminology. Summary contains controlled topic terminology. Source terminology contains a controlled topic term. Title supplies ageing or longevity context.

Automated source check 100% · update recency 85%. These figures help sort records; they are not medical ratings.

cancer and aging
Read the original source →Export JSON